Skip to content

Effects of Family Sodium Watcher Program on Outcomes in Heart Failure Patient-Family Caregiver Dyads

Effects of Family Sodium Watcher Program on Outcomes in Heart Failure Patient-Family Caregiver Dyads

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03560206
Acronym
FAMSWAP
Enrollment
316
Registered
2018-06-18
Start date
2015-03-01
Completion date
2020-07-31
Last updated
2022-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Keywords

Diet, low-sodium, caregivers

Brief summary

The Family Sodium Watcher program in this study is designed to improve adherence to a sodium restricted diet in patients with HF using strategies that educate both patients and family caregivers about sodium monitoring and that stress a gradual progressive adaptation to low sodium food for both patients and family caregivers.

Detailed description

Heart failure (HF) emerged as a significant public health threat in the 1990s and has now reached epidemic proportions. Despite advances in the medical treatment of HF, patients with HF face frequent hospitalizations for acute exacerbations. Inadequate self-care strategies, in particular non-adherence to a sodium restricted diet (SRD), is a main cause of these rehospitalizations. Prior interventions to increase adherence have focused on increasing knowledge about restricting sodium in the diet have met with limited success. Unaddressed by these interventions are the major barriers of measuring and tracking daily sodium intake, family members who continue to eat high sodium diets, and a preference for salty foods-particularly in the elderly who have a decreased sense of taste. It is possible to retrain the taste buds to enjoy low salt foods by gradually reducing the amount of sodium in foods over the course of 16 weeks. This retraining works best with direct involvement and support from family members. The Family Sodium Watcher Program (Family SWaP) proposed in this study incorporates the use of a unique electronic salt monitoring device that easily measures salt content in food-the major source of sodium. The intervention is designed to improve adherence to a SRD by both patients and family caregivers through education and strategies for gradual taste adaptation to low salt foods.

Interventions

BEHAVIORALFamily SWaP intervention

The Family Sodium Watcher Program (Family SWaP) proposed in this study incorporates the use of a unique electronic salt monitoring device that easily measures salt content in food-the major source of sodium. The intervention is designed to improve adherence to a sodium restricted diet by both patients and family caregivers through education and strategies for gradual taste adaptation to low salt foods. The Family SWaP intervention (6 weekly 45-minute sessions followed by 5 bi-weekly booster sessions) will be delivered remotely using a video-conferencing program on an iPad tablet.

BEHAVIORALusual care

The usual care group will receive their routine medical and nursing care for heart failure that consists of a recommendation to follow a sodium restricted diet without explicit skills training to do so.

Sponsors

National Institute of Nursing Research (NINR)
CollaboratorNIH
Misook L. Chung
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)

Intervention model description

a randomized controlled trial

Eligibility

Sex/Gender
ALL
Age
21 Years to 90 Years
Healthy volunteers
Yes

Inclusion criteria

Eligible patients will: * have diagnosis of chronic HF with either preserved or reduced ejection fraction * have a dedicated primary family caregiver * be able to speak and write English Eligible caregivers will: * be a primary caregiver identified by the patient * the spouse, committed partner, or family member living with the HF patient * be able to speak and understand English * have no obvious major clinical cognitive impairment that would impair ability to give informed consent * have no major co-morbidities (i.e. HF, cancer, renal/liver failure, or uncontrolled diabetes as determined by self-report).

Exclusion criteria

Patients will be excluded if they have: * major clinical cognitive impairment (i.e., dementia, Alzheimer disease, and severe stroke) * a co-existing terminal illness (e.g., cancer) * a referral for heart transplantation * a dietary prescription that prevents following a 2-3 gram sodium diet (e.g., clinician does not support use of a SRD). * no dedicated caregivers

Design outcomes

Primary

MeasureTime frameDescription
Patients' Adherence to Sodium-restricted Diet Assessed by Urinary Sodium Excretion LevelsUp to 1 yearBaseline: Patient adherence to a sodium-restricted diet was assessed using 24-hour urinary sodium excretion at 3-time points at baseline, 4-months, and 12 months.

Secondary

MeasureTime frameDescription
All Cause Hospitalization/Mortality12 monthsData for all events of hospitalizations and mortality were collected from the baseline to 12 months follow up.

Countries

United States

Participant flow

Recruitment details

We recruited a total of 316 individuals consisting of 158 patients with heart failure and 158 primary caregivers at outpatient cardiology clinics in one academic medical center and one community medical center.

Pre-assignment details

As a result of the screening of 5,365 patients, a total of 819 dyads who met the inclusion criteria and 214 dyads verbally agreed to participate (26.1% recruitment rate). Of these, 199 dyads provided written consent,but 41 dyads withdrew before the home visit for baseline data collection. Thus, only158 dyads (316 individuals: 158 patients and 158 caregivers) completed the baseline assessment. Thus, we reported the final sample of 158 patients with heart failure in this report.

Participants by arm

ArmCount
Family SWaP Intervention
an educational-behavioral intervention consisting of 6 weekly education sessions (45 minutes) followed by 5 bi-weekly sessions (15-20 minutes) that will be held at the dyad's preferred time delivered to their homes using a video conferencing program through a mini iPad. Family SWaP intervention with mini iPad: The Family Sodium Watcher Program (Family SWaP) proposed in this study incorporates the use of a unique electronic salt monitoring device that easily measures salt content in food-the major source of sodium. The intervention is designed to improve adherence to a sodium restricted diet by both patients and family caregivers through education and strategies for gradual taste adaptation to low salt foods. The Family SWaP intervention (6 weekly 45-minute sessions followed by 5 bi-weekly booster sessions) will be delivered remotely using a video-conferencing program on an iPad tablet.
158
Usual Care
The usual care group will receive their routine medical and nursing care for heart failure that consists of a recommendation to follow a sodium restricted diet without explicit skills training to do so. usual care: The usual care group will receive their routine medical and nursing care for heart failure that consists of a recommendation to follow a sodium restricted diet without explicit skills training to do so.
158
Total316

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyBusy schedule142
Overall Studycaregivers' health condition and not becoming non-caregiver50
Overall StudyLost to Follow-up1911
Overall Studypatients' new health condition such as cancer101
Overall StudyWithdrawal by Subject24

Baseline characteristics

CharacteristicFamily SWaP InterventionUsual CareTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
58 Participants60 Participants118 Participants
Age, Categorical
Between 18 and 65 years
100 Participants98 Participants198 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
2 Participants2 Participants4 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
156 Participants156 Participants312 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
1 Participants1 Participants2 Participants
Race (NIH/OMB)
Black or African American
29 Participants23 Participants52 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
3 Participants2 Participants5 Participants
Race (NIH/OMB)
White
125 Participants132 Participants257 Participants
Region of Enrollment
United States
158 participants158 participants316 participants
Sex: Female, Male
Female
88 Participants86 Participants174 Participants
Sex: Female, Male
Male
70 Participants72 Participants142 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
4 / 1582 / 158
other
Total, other adverse events
0 / 1580 / 158
serious
Total, serious adverse events
23 / 15828 / 158

Outcome results

Primary

Patients' Adherence to Sodium-restricted Diet Assessed by Urinary Sodium Excretion Levels

Baseline: Patient adherence to a sodium-restricted diet was assessed using 24-hour urinary sodium excretion at 3-time points at baseline, 4-months, and 12 months.

Time frame: Up to 1 year

Population: Of the 158 patient-caregiver dyads (158 patients with heart failure and 158 primary caregivers), we report the primary outcome of patient adherence to the sodium-restricted diet. Of the 158 patients with heart failure, 79 patients were randomly assigned to the Family Sodium Watchers intervention group and another 79 patients were assigned to the usual care group.

ArmMeasureGroupValue (MEAN)Dispersion
Family SWaP InterventionPatients' Adherence to Sodium-restricted Diet Assessed by Urinary Sodium Excretion LevelsBaseline4390.2 mg/dayStandard Deviation 2286.1
Family SWaP InterventionPatients' Adherence to Sodium-restricted Diet Assessed by Urinary Sodium Excretion Levels4-month3338.1 mg/dayStandard Deviation 1580.1
Family SWaP InterventionPatients' Adherence to Sodium-restricted Diet Assessed by Urinary Sodium Excretion Levels12-month3523.1 mg/dayStandard Deviation 2173.3
Usual CarePatients' Adherence to Sodium-restricted Diet Assessed by Urinary Sodium Excretion LevelsBaseline4048.9 mg/dayStandard Deviation 1969.6
Usual CarePatients' Adherence to Sodium-restricted Diet Assessed by Urinary Sodium Excretion Levels4-month4402.9 mg/dayStandard Deviation 2214.6
Usual CarePatients' Adherence to Sodium-restricted Diet Assessed by Urinary Sodium Excretion Levels12-month3855.3 mg/dayStandard Deviation 1446.6
Secondary

All Cause Hospitalization/Mortality

Data for all events of hospitalizations and mortality were collected from the baseline to 12 months follow up.

Time frame: 12 months

Population: Events included death and hospitalization events for participants.

ArmMeasureValue (NUMBER)
Family SWaP InterventionAll Cause Hospitalization/Mortality23 first event during follow up
Usual CareAll Cause Hospitalization/Mortality28 first event during follow up

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026